Caring for patients using mitragynine-derived substances
Familiarize yourself with the differences in mitragynine-derived compounds. Understand how to identify and manage kratom use disorder and withdrawal from mitragynine-derived compounds. We’re joined by Dr. Jonathan Tanawan (Profile).
Claim CME for this episode at curbsiders.vcuhealth.org!
By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.
Episodes | Subscribe | Spotify | iTunes | [email protected] | CME!
Credits
Written and Produced, with Show Notes, Infographic, and Cover Art by Zina Huxley-Reicher, MD Hosts: Carolyn Chan, MD. MHS and Zina Huxley-Reicher, MDReviewer: Kento Sonoda, MD, MPHShowrunner: Carolyn Chan, MD, MHSTechnical Production: PodPasteGuest: Jonathan Tanawan, MDIntro, disclaimer, guest bioGuest one-liner, Picks of the Week*Case from Kashlak; DefinitionsPharmacology of kratom and other mitragynine-based compoundsHow to take a mitragynine-specific substance use historyDefining a use disorderWithdrawal from kratom Managing a use disorder with MOUDLegal landscape and regulation Outro
Sponsor: Freed
Go to freed.ai and use code FREED50 for fifty dollars off your first month.
Sponsor: Figs
Curbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX.
Sponsor: Continuing Education Company
Visit CMEmeeting.org/curbsiders and use promo code Curb30 for 30% off all online courses and webcasts.